Comparison

Setipiprant European Partner

€30.00
Excl. VAT
Item no. TMO-T3520-5mg
Manufacturer TargetMol
CASRN 866460-33-5
Amount 5mg
Category
Type Molecules
Specific against other
Citations 1. Diamant Z., et al. Setipiprant, a selective CRTH2 antagonist, reduces allergen-induced airway responses in allergic asthmatics. Clin Exp Allergy. 2014 Aug;44(8):1044-52.
Smiles C1CN(CC2=C1N(C3=C2C=C(C=C3)F)CC(=O)O)C(=O)C4=CC=CC5=CC=CC=C54
ECLASS 10.1 32169090
ECLASS 11.0 32169090
UNSPSC 12000000
Alias GPR antagonist, ACT-129968 , KYTH-105
Available
Short Description
Setipiprant is an orally available, selective CRTH2 antagonist (IC50: 6.0 nM). CRTH2 is a G protein-coupled receptor for prostaglandin (PGD2). PGD2 is produced by the mast cells and is a key mediator in various inflammatory diseases, including allergy and asthma. Binding of PGD2 to CRTH2, which are expressed on the surface of blood-borne cells, induces chemotaxis of Th2 cells, basophils, and eosinophils, and stimulates cytokine release from these cells.
Shipping
cool pack
Storage
-20°
Target names or alias
ACT-129968 , KYTH-105
Molecular Weight
402, 42
Pathway
Immunology/Inflammation|||Endocrinology/Hormones|||GPCR/G Protein
Target
Prostaglandin Receptor|||GPR

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 5mg
Available: In stock
Listprice: €30.00
Price: €30.00
available

Delivery expected until 8/21/2025 

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close